Copyright
©The Author(s) 2022.
World J Hepatol. Jun 27, 2022; 14(6): 1226-1234
Published online Jun 27, 2022. doi: 10.4254/wjh.v14.i6.1226
Published online Jun 27, 2022. doi: 10.4254/wjh.v14.i6.1226
Variables | ALL (n = 437) | Fatty liver (n = 110) | Non-fatty liver (n = 327) | P value |
Gender (Male/Female) | 269/168 | 80/30 | 189/138 | 0.005 |
Age (yr) | 74.0 ± 13.0 | 64.7 ± 13.0 | 77.1 ± 11.0 | < 0.001 |
Height (cm) | 159.4 ± 10.2 | 163.2 ± 10.0 | 158.2 ± 9.9 | < 0.001 |
Body weight (kg) | 61.3 ± 14.5 | 70.0 ± 16.6 | 58.5 ± 12.5 | < 0.001 |
BMI (kg/m2) | 24.0 ± 4.9 | 26.0 ± 4.7 | 23.3 ± 4.7 | < 0.001 |
HbA1c (%) | 7.0 ± 1.2 | 7.2 ± 1.2 | 6.9 ± 1.2 | 0.066 |
Blood glucose (mg/dl) | 164 ± 80 | 170 ± 116 | 161 ± 63 | 0.297 |
White blood cells (/μL) | 6618 ± 2299 | 7056 ± 1649 | 6470 ± 2463 | 0.021 |
Hemoglobin (g/dL) | 12.6 ± 2.4 | 14.2 ± 2.1 | 12.0 ± 2.2 | < 0.001 |
Platelets (104/μL) | 20.7 ± 7.0 | 20.4 ± 5.5 | 20.8 ± 7.4 | 0.615 |
Prothrombin time (%) | 89.6 ± 22.3 | 89.2 ± 23.6 | 89.7 ± 22.1 | 0.895 |
Albumin (g/dL) | 3.7 ± 0.7 | 3.9 ± 0.6 | 3.6 ± 0.6 | < 0.001 |
Total bilirubin (mg/dL) | 0.76 ± 0.50 | 0.86 ± 0.49 | 0.72 ± 0.49 | 0.015 |
ALP (U/L) | 266 ± 156 | 247 ± 80 | 272 ± 176 | 0.182 |
AST (U/L) | 25.3 ± 22.8 | 29.0 ± 20.2 | 23.0 ± 23.4 | 0.014 |
ALT (U/L) | 23.5 ± 20.8 | 35.0 ± 27.4 | 19.0 ± 16.1 | < 0.001 |
GGT (U/L) | 46.2 ± 63.1 | 68.0 ± 74.4 | 38.0 ± 56.6 | < 0.001 |
Creatinine (mg/dL) | 1.71 ± 2.10 | 1.27 ± 1.58 | 1.85 ± 2.22 | 0.012 |
eGFR (mL/min) | 52.0 ± 29.2 | 58.9 ± 21.9 | 49.6 ± 30.9 | 0.004 |
Total cholesterol (mg/dL) | 181 ± 50 | 193 ± 64 | 177 ± 43 | 0.012 |
HDL cholesterol (mg/dL) | 53 ± 17 | 50 ± 15 | 54 ± 17 | 0.039 |
Triglyceride (mg/dL) | 160 ± 179 | 228 ± 299 | 134 ± 87 | < 0.001 |
LDL cholesterol (mg/dL) | 101 ± 36 | 111 ± 40 | 96 ± 33 | 0.001 |
FIB-4 index | 2.20 ± 1.56 | 1.84 ± 1.08 | 2.32 ± 1.67 | 0.005 |
Cirrhosis (%) | 8 (1.8) | 1 (0.9) | 7 (2.1) | 0.405 |
Hepatocellular carcinoma (%) | 7 (1.6) | 1 (0.9) | 6 (1.8) | 0.504 |
Cerebrovascular accident (%) | 45 (10) | 9 (8.2) | 36 (11) | 0.399 |
Cardiovasculart disease (%) | 137 (31) | 29 (26) | 108 (33) | 0.193 |
Dyslipidemia (%) | 205 (47) | 53 (48) | 152 (46) | 0.758 |
Hypertension (%) | 270 (62) | 57 (51) | 213 (65) | 0.013 |
Dialysis (%) | 45 (10) | 3 (2.7) | 42 (12) | 0.003 |
- Citation: Yamane R, Yoshioka K, Hayashi K, Shimizu Y, Ito Y, Matsushita K, Yoshizaki M, Kajikawa G, Mizutani T, Watarai A, Tachi K, Goto H. Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus. World J Hepatol 2022; 14(6): 1226-1234
- URL: https://www.wjgnet.com/1948-5182/full/v14/i6/1226.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i6.1226